Breaking News Instant updates and real-time market news.

UUP

PowerShares DB US Dollar Index Up

$26.30

0.135 (0.52%)

, FCEL

FuelCell

$0.35

0.0498 (16.60%)

08:45
07/22/19
07/22
08:45
07/22/19
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: PowerShares DB US Dollar Index Bullish Fund (UUP) 5.96% +1.05, FuelCell (FCEL) 86.04% +0.71, Canopy Growth (CGC) 31.36% +0.49, Aphria (APHA) 48.32% +0.19, FAS (FAS) 1.01% +0.18, Immunomedics (IMMU) 0.39% +0.05, Sally Beauty (SBH) 0.31% +0.03, db X trackers China (ASHR) 3.15% +0.02, Vici Properties (VICI) 0.40% +0.02, and Electronic Arts (EA) 0.41% +0.01.

UUP

PowerShares DB US Dollar Index Up

$26.30

0.135 (0.52%)

FCEL

FuelCell

$0.35

0.0498 (16.60%)

CGC

Canopy Growth

$35.48

-0.315 (-0.88%)

APHA

Aphria

$6.39

-0.05 (-0.78%)

IMMU

Immunomedics

$14.92

-0.38 (-2.48%)

SBH

Sally Beauty

$12.18

-0.12 (-0.98%)

ASHR

X-trackers Harvest CSI 300

$27.82

0.01 (0.04%)

VICI

VICI Properties

$21.64

-0.34 (-1.55%)

EA

Electronic Arts

$87.47

-1.74 (-1.95%)

  • 30

    Jul

  • 01

    Aug

  • 01

    Aug

  • 08

    Aug

  • 09

    Sep

  • 13

    Nov

UUP PowerShares DB US Dollar Index Up
$26.30

0.135 (0.52%)

FCEL FuelCell
$0.35

0.0498 (16.60%)

06/06/19
OPCO
06/06/19
DOWNGRADE
OPCO
Perform
Oppenheimer downgrades FuelCell to Perform on restructuring, CEO exit
Oppenheimer analyst Colin Rusch downgraded FuelCell Energy to Perform from Outperform without a price target. With the company entering into a full restructuring via Huron Consulting and CEO Chip Bottone being terminated, its strategy for moving forward "has become increasingly more difficult to predict," Rusch tells investors in a research note. The analyst had anticipated FuelCell would restructure its debt, but he says it is now unclear how it will move forward both from a capital structure and also from a management perspective. As a result, Rusch is stepping to the sidelines" until a strategy and leadership team is in place."
06/06/19
OPCO
06/06/19
DOWNGRADE
OPCO
Perform
FuelCell downgraded to Perform from Outperform at Oppenheimer
06/06/19
COWN
06/06/19
DOWNGRADE
Target $1
COWN
Market Perform
FuelCell downgraded to Market Perform from Outperform at Cowen
Cowen analyst Jeffrey Osborne downgraded FuelCell to Market Perform from Outperform and lowered his price target on the shares to $1.00 from $2.75 following the company's announcement of the hiring of a restructuring firm and dismissal of its CEO.
06/06/19
06/06/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Qorvo (QRVO) downgraded to Equal Weight from Overweight at Barclays with analyst Blayne Curtis citing the company's higher relative valuation, concerns of increased radio frequency competition, and potential further impacts from the trade war for the downgrade. 2. Spirit Airlines (SAVE) downgraded to Neutral from Buy at Goldman Sachs with analyst Catherine O'Brien saying there is downside risk to the consensus earnings forecasts for Spirit while United's estimates have appropriately incorporated tougher second half 2019 comparables. 3. Orange SA (ORAN) downgraded to Equal Weight from Overweight at Morgan Stanley. 4. Cloudera (CLDR) downgraded two notches to Hold from Strong Buy at Needham, to Neutral from Buy at Citi, to Hold from Buy at Stifel, and to Market Perform from Outperform at Raymond James. 5. FuelCell (FCEL) downgraded to Perform from Outperform at Oppenheimer and to Market Perform from Outperform at Cowen. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CGC Canopy Growth
$35.48

-0.315 (-0.88%)

07/08/19
PIPR
07/08/19
NO CHANGE
Target $54
PIPR
Overweight
Canopy Growth price target lowered to $54 from $57 at Piper Jaffray
Piper Jaffray analyst Michael Lavery lowered his price target for Canopy Growth to $54 from $57 citing the company's slower than expected retail rollout. The analyst, however, reiterates an Overweight rating on the shares. Further retail openings in Canada, especially Ontario, will drive Canopy's market growth, but they continue to progress at a very slow pace, Lavery tells investors in a research note. California has $200M in monthly sales while Canada has only $60M, despite similar population sizes, the analyst points out. Further, Lavery believes the termination of Co-CEO Bruce Linton "likely signals more discipline to come." A successor could bring a more disciplined approach that investors are likely to welcome, contends the analyst.
07/17/19
LTCO
07/17/19
INITIATION
Target $50
LTCO
Buy
Canopy Growth initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Glenn Mattson started Canopy Growth with a Buy rating and $50 price target. Within the cannabis space, the analyst favors Canadian companies who are focused on long-term value creation and gaining market share as well as those with a well-defined plan for potentially entering the U.S. market. He initiated coverage on the cannabis space with a "bullish long-term outlook." Despite slower than expected growth in the most recently reported quarter, Canopy Growth remains one of the best ways to play the cannabis space, Mattson tells investors in a research note. Given its "significant" balance sheet, Canopy has the greatest flexibility to go after new growth opportunities as they emerge, says the analyst.
07/17/19
LTCO
07/17/19
INITIATION
Target $18
LTCO
Buy
Acreage Holdings initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Glenn Mattson started Acreage Holdings (ACRGF) with a Buy rating and $18 price target. Within the cannabis space, the analyst favors Canadian companies who are focused on long-term value creation and gaining market share as well as those with a well-defined plan for potentially entering the U.S. market. He initiated coverage on the cannabis space with a "bullish long-term outlook." Acreage has a "solid position" in the most attractive areas of the U.S., Mattson tells investors in a research note. Further, the company trades at a "significant discount" to the implied conversion from the proposed Canopy Growth (CGC) transaction, which will execute upon federal legalization of cannabis in the U.S., the analyst ads.
07/05/19
07/05/19
DOWNGRADE

Canopy Growth downgraded to Neutral from Buy at Bryan Garnier
Bryan Garnier analyst Nikolaas Faes yesterday downgraded Canopy Growth to Neutral from Buy and lowered his price target for the shares to C$60 from C$85.
APHA Aphria
$6.39

-0.05 (-0.78%)

04/16/19
VERF
04/16/19
NO CHANGE
Target $8
VERF
Sell
Use Aphria results as guide and short Tilray shares, says Vertical Group
Vertical Group analyst Gordon Johnson tells investors to use Aphria's (APHA) fiscal Q3 results as a guide and build a short position in Tilray (TLRY). The analyst last week initiated coverage of Tilray with a Sell rating and $8 year-end price target. Despite expectations for growth in Canadian sales due to the growth expectations for the recreational cannabis market, Aphria's kilograms sold fell 22.7% quarter-over-quarter in the quarter reported yesterday, Johnson tells investors in an email to clients. The analyst maintains his negative bias on Tilray following Aphia's results. Shares of Tilray are up 54c to $49.78 in early trading.
05/24/19
JEFF
05/24/19
INITIATION
JEFF
Buy
Jefferies starts Aphria at Buy, says valuation 'not reflective of reality'
Jefferies analyst Owen Bennett initiated coverage of Aphria (APHA) with a Buy rating and C$15 price target. The stock closed yesterday down 33c to $6.41. The analyst says the company scores highly on his "strategic scorecard," or third overall behind only Canopy Growth (CGC) and Aurora Cannabis (ACB). Despite a "strong global outlook," Aphria's valuation is the cheapest across the space, with allegations around inflated assets/insider deals weighing on the shares, Bennett tells investors in a research note. The analyst expects a "significant re-rating" in the shares with "these issues now seemingly cleared up." He points out that the company's questionable relationships have been severed and a special committee review found assets had not been falsely inflated. Bennett believes Aphria continues to execute and that its valuation is "not reflective of reality."
05/24/19
05/24/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Zoom Video (ZM) initiated with a Perform at Oppenheimer. 2. CannTrust (CTST) initiated with a Buy at BofA/Merrill. 3. Inseego (INSG) initiated with an Outperform at Cowen. 4. Falcon Minerals (FLMN) initiated with an Outperform at Baird. 5. Aphria (APHA) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/10/19
PIPR
06/10/19
NO CHANGE
PIPR
Cannabis regulation could become top 2020 election issue, says Piper Jaffray
After Washington D.C. lobbyist Michael Esposito, who also works closely with President Trump's administration, spoke at his firm's conference, Piper Jaffray analyst Michael Lavery believes cannabis regulation could become a top 2020 election issue. By supporting cannabis, Trump may be able to incrementally broaden his appeal with swing voters without alienating his base, Esposito tells investors in a research note. Though Trump has indicated his willingness to support the STATES Act, his enthusiasm could depend on whether or not Elizabeth Warren, author of the bill, is his opponent, adds the analyst in a note titled "Handicapping US Legalization Outlook: Politics Are Complicated." And while Senate Majority Leader Mitch McConnell is a roadblock for legislation in the Senate, Trump could use executive orders between now and the election to show support for the industry, potentially relating to cannabis banking or medical research, says Lavery. The analyst has Overweight ratings on both Canopy Growth (CGC) and Tilray (TLRY). Other names in the space include Aphria (APHA), Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC), MediPharm Labs (MLCPF) and Zynerba (ZYNE).
IMMU Immunomedics
$14.92

-0.38 (-2.48%)

04/08/19
PIPR
04/08/19
NO CHANGE
Target $20
PIPR
Overweight
Immunomedics deal with J&J indicates sacituzumab re-filing, says Piper Jaffray
Immunomedics (IMMU) this morning announced that it has entered into an agreement with Johnson & Johnson (JNJ) to provide detailing services to J&J for erdafitinib in the U.S. through Q1 of 2020, Piper Jaffray analyst Joseph Catanzaro tells investors in a research note. The analyst believes the deal will provide incremental revenue to Immunomedics while allowing the company to keep its sacituzumab-trained sales team on board while offsetting some of the costs. Further, the Q1 of 2020 termination suggests a potential timeline for a sacituzumab re-filing and approval, says Catanzaro, who notes Immunomedics has not yet provided guidance. The analyst remains comfortable with his mid-2020 approval timing for sacituzumab and keeps an Overweight rating on Immunomedics with a $20 price target.
04/29/19
PIPR
04/29/19
NO CHANGE
Target $20
PIPR
Overweight
Piper says Immunomedics' licensing terms for sacituzumab 'very favorable'
After Immunomedics announced a partnership with Everest Medicines to commercialize sacituzumab for all cancer indications in Asian countries including China and South Korea, Piper Jaffray analyst Joseph Catanzaro called the terms of the deal "very favorable," adding that he believes they "set a new benchmark for greater China licensing deals." Catanzaro also addressed the news that Chief Medical Officer Rob Iannone has decided to leave the company for personal reasons, telling investors that he does not believe the change will affect the company's resubmission process for sacituzumab's BLA. The analyst keeps an Overweight rating and $20 price target on Immunomedics shares.
04/30/19
HCWC
04/30/19
NO CHANGE
Target $29
HCWC
Buy
Immunomedics pullback brings favorable entry point, says H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju says the recent weakness in shares of Immunomedics creates a favorable entry point. The analyst views the company's licensing agreement with China's Everest Medicines as favorable and upped his price target for the shares to $29 from $28. Everest's expertise around development, regulatory affairs, and commercialization in Asian markets should enable IMMU-132 to enter those markets in the most expeditious timeframe, Selvaraju tells investors in a research note. He reiterates a Buy rating on Immunomedics.
05/09/19
PIPR
05/09/19
NO CHANGE
Target $20
PIPR
Overweight
Immunomedics refiling timeline should bring some relief, says Piper Jaffray
Immunomedics indicated that it is now in broad alignment with the FDA around the issues raised in the Complete Response Letter and is projecting a biologics license application resubmission for sacituzumab to occur in early Q4, Piper Jaffray analyst Joseph Catanzaro tells investors in a post-earnings research note. The analyst believes this timeline is largely in-line with consensus and should provide a "bit of relief." Investors may still have some questions around the Ascent trial timing, but given the FDA's apparent comfort with the clinical data, a further approval delay is unlikely given the extreme unmet need in triple-negative breast cancer, adds the analyst. He maintains an Overweight rating on Immunomedics with a $20 price target.
SBH Sally Beauty
$12.18

-0.12 (-0.98%)

07/12/19
JEFF
07/12/19
UPGRADE
Target $12
JEFF
Hold
Sally Beauty upgraded to Hold on valuation at Jefferies
Jefferies analyst Stephanie Wissink upgraded Sally Beauty Holdings to Hold from Underperform while lowering her price target for the shares to $12 from $14. The near-term effects of intensifying competition are fairly reflected in shares at current levels, Wissink tells investors in a research note. The analyst, however, says she lacks "discrete conviction" in Sally Beauty's long-term fundamentals.
07/12/19
JEFF
07/12/19
UPGRADE
Target $12
JEFF
Hold
Sally Beauty upgraded to Hold from Underperform at Jefferies
Jefferies analyst Stephanie Wissink upgraded Sally Beauty Holdings to Hold from Underperform while lowering her price target for the shares to $12 from $14.
06/25/19
OPCO
06/25/19
NO CHANGE
OPCO
Perform
Amazon entrance to likely continue to depress Sally's multiple, says Oppenheimer
Oppenheimer analyst Rupesh Parikh notes that Amazon (AMZN) Business announced the launch of the Amazon Professional Beauty store and that he spoke with Sally Beauty (SBH) management. Given the exclusivity the BSG side of the business has with key brands, the analyst think announcement would have a minimal nearer-term impact on Sally's business. Nonetheless, Parikh believes Amazon's entrance and interest in the category will likely continue to depress Sally Beauty's multiple to even lower levels until the company can demonstrate the ability to return to positive comp growth on a sustainable base. For now, Ulta Beauty (ULTA) and Estee Lauder (EL) remain his top beauty picks. The analyst has a Perform rating on Sally Beauty's shares.
06/25/19
DADA
06/25/19
NO CHANGE
Target $14
DADA
Neutral
Sally Beauty price target lowered to $14 from $16.50 at DA Davidson
DA Davidson analyst Linda Bolton Weiser lowered her price target for Sally Beauty (SBH) to $14 from $16.50 following the launch of Amazon's (AMZN) professional beauty store. In a research note to investors, the analyst says she estimates 19% of Sally Beauty's operating profit is directly threatened, with an additional 33% potentially at risk for increased competition.
ASHR X-trackers Harvest CSI 300
$27.82

0.01 (0.04%)

VICI VICI Properties
$21.64

-0.34 (-1.55%)

06/18/19
LTCO
06/18/19
NO CHANGE
LTCO
VICI Properties acquisition may signal further deals, says Ladenburg
Ladenburg analyst John Massocca reiterated a Buy rating and $26 price target on VICI Properties. The analyst noted that while its recently announced acquisition of three casino properties should be "strongly accretive," it may also signal "a trend of consolidation with smaller casinos that could drive further deal flow."
07/01/19
WELS
07/01/19
UPGRADE
Target $24.5
WELS
Outperform
VICI Properties upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Jeffrey Donnelly upgraded VICI Properties (VICI) to Outperform from Market Perform and raised his price tare for the shares to $24.50 from $23. The company's recent partnership announcement with Eldorado Resorts (ERI) will increase its rent base by $252.5M, Donnelly tells investors in a research note. The analyst believes the deal is positive for VICI given its 6% earnings accretion, improved lease terms, and replenished pipeline for future acquisitions. In addition, the continued institutionalization of the gaming real estate investment trust sector should allow for more cap rate compression within the asset class over time, says Donnelly.
06/11/19
MSCO
06/11/19
NO CHANGE
MSCO
Morgan Stanley raises price targets on three Gaming REITs
Morgan Stanley analyst Thomas Allen said he thinks Gaming REITs will look attractive as those in the market look for defensive ideas and while he does not think the group will re-rate to parity with the best-in-class of traditional Triple Net REITs, he does see room for margin expansion. In that context, he raised his price target on Gaming and Leisure Properties (GLPI) to $48 from $42, on MGM Growth (MGP) to $35 from $33 and on VICI Properties (VICI) to $25 from $24. He keeps an Outperform rating on Gaming and Leisure shares and has Neutral ratings on the other two Gaming REITs mentioned.
06/11/19
GSCO
06/11/19
UPGRADE
Target $29
GSCO
Buy
Goldman upgrades Red Rock to Buy, sees 35% total return potential
Goldman Sachs analyst Stephen Grambling upgraded Red Rock Resorts (RRR) to Buy from Neutral while lowering his price target for the shares to $29 from $31. The analyst sees 35% total return potential in the stock as he believes a successful Palms ramp and free cash flow "inflection" in 2020 can drive a "sustained re-rating." Further, he believes Red Rock has optionality from a positive Locals Las Vegas macro backdrop and land development/sales. In addition, the company's underlying real estate provides downside valuation support, Grambling tells investors in a research note. The analyst also reiterates Buy ratings on both Las Vegas Sands (LVS) and VICI Properties (VICI).
EA Electronic Arts
$87.47

-1.74 (-1.95%)

07/16/19
PIPR
07/16/19
NO CHANGE
PIPR
Overweight
Piper video game viewing data most favorable for Activision Blizzard
Piper Jaffray analyst Michael Olson says his firm's Q2 "TwitchAdviser," an analysis of video game viewing data, is most favorable for Activision Blizzard (ATVI), with additional positive takeaways for Take-Two Interactive (TTWO). Activision viewership is up 15% quarter-over-quarter, versus the analyst's estimate for a 3% digital revenue decline, excluding King, Olson tells investors in a research note. Take-Two viewing increased 149% quarter-over-quarter versus Olson's estimate for a 26% decline in recurrent revenue. That much of an uptick in viewership is unlikely to result in a recurrent revenue increase of similar magnitude, given much of the viewing for Grand Theft Auto s driven by un-monetized modding, the analyst tells investors in a research note. Further, for the second consecutive quarter, Electronic Arts' (EA) Apex Legends was among the top movers, but this time on a downward trajectory, adds Olson. He maintains Overweight ratings on all three names.
07/17/19
JEFF
07/17/19
NO CHANGE
Target $100
JEFF
Hold
Electronic Arts loss of Juventus deal a 'non-issue,' says Jefferies
Shares of Electronic Arts traded down 3% yesterday as main competitor Pro Evolution Soccer announced an exclusive licensing deal with popular Italian football club Juventus, Jefferies analyst Alex Giaimo tells investors in a research note. Importantly, the does not include exclusive rights to the players themselves, meaning all Juventus players and attributes will still be featured in FIFA 20, adds the analyst. Electronic Arts released a statement confirming the news, and announced a new club named "Piemonte Calcio", which will essentially be the fill-in team name for Juventus, notes Giaimo. The analyst views yesterday's news as a "non-issue." The company's FIFA franchise has built up enough goodwill over the past 26 years, making it hard to believe loss of rights to one club would be enough to turn off potential player, says Giaimo. The analyst, despite believing the Juventus concerns are overblown, keeps a Hold rating on Electronic Arts due to "mixed Apex sentiment."
07/16/19
SPHN
07/16/19
NO CHANGE
Target $120
SPHN
Overweight
Electronic Arts weakness on Juventus news a buying opportunity, says Stephens
Stephens analyst Jeff Cohen noted that Konami announced a deal with Italian soccer club Juventus to appear exclusively in the Japanese developer's "Pro Evolution Soccer," which means Electronic Arts' FIFA 20 will not feature Juventus or the team's stadium. While he recognizes that Cristiano Ronaldo, the game's most recognizable player, plays for Juventus, Cohen also noted that EA stated in a blog post that the company will still have the name and likeness of all of Juventus' players and will simply rename the team in its game. Cohen said he sees this as a one-off agreement, rather than a sign of increasing competition for EA, and he would be a buyer of the shares amid today's weakness. He keeps an Overweight rating and $120 price target on the stock.
07/19/19
PIPR
07/19/19
NO CHANGE
PIPR
Overweight
June quarter NPD data positive for Take-Two, Activision, says Piper Jaffray
NPD video game sales data dropped 13% for the full June quarter, Piper Jaffray analyst Michael Olson tells investors in a research note. The June quarter NPD results are positive for Take-Two (TTWO) and Activision Blizzard (ATVI), with the data ahead of expectations, Olson tells investors in a research note. He adds the results are less positive for Electronic Arts (EA), but points out the data includes a difficult compare with the World Cup and does not include Apex Legends. Olson maintains Overweight ratings on all three names.

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$1,232.55

-7.05 (-0.57%)

, GOOGL

Alphabet Class A

$1,232.30

-5.91 (-0.48%)

15:04
09/20/19
09/20
15:04
09/20/19
15:04
Hot Stocks
YouTube CEO apologizes to creators for 'new approach to verification' »

YouTube CEO Susan…

GOOG

Alphabet

$1,232.55

-7.05 (-0.57%)

GOOGL

Alphabet Class A

$1,232.30

-5.91 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Oct

MGM

MGM Resorts

$28.92

-0.14 (-0.48%)

, BX

Blackstone

$52.46

-0.45 (-0.85%)

15:00
09/20/19
09/20
15:00
09/20/19
15:00
Periodicals
MGM Resorts in talks to sell Circus Circus casino to Phil Ruffin, Bloomberg says »

MGM Resorts (MGM) is in…

MGM

MGM Resorts

$28.92

-0.14 (-0.48%)

BX

Blackstone

$52.46

-0.45 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

TGT

Target

$107.36

-0.48 (-0.45%)

15:00
09/20/19
09/20
15:00
09/20/19
15:00
Options
Buyer pays 12c over parity for deep in the money expiring Sep 87.5 calls »

Buyer pays 12c over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CAG

Conagra Brands

$29.95

0.3 (1.01%)

14:55
09/20/19
09/20
14:55
09/20/19
14:55
Options
ConAgra put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 01

    Oct

14:50
09/20/19
09/20
14:50
09/20/19
14:50
General news
Fed's Kaplan said he backed the Fed's rate cuts in September and July »

Fed's Kaplan said he…

FB

Facebook

$189.71

-0.44 (-0.23%)

14:48
09/20/19
09/20
14:48
09/20/19
14:48
Hot Stocks
Facebook says has suspended 'tens of thousands' of apps over data use »

In a blog post, Facebook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

SKT

Tanger Factory

$15.90

0.13 (0.82%)

14:35
09/20/19
09/20
14:35
09/20/19
14:35
Options
Tanger Factory put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:35
09/20/19
09/20
14:35
09/20/19
14:35
General news
Action Economics Survey results: »

Action Economics Survey…

USAT

USA Technologies

$7.43

-0.22 (-2.88%)

14:31
09/20/19
09/20
14:31
09/20/19
14:31
Hot Stocks
Breaking Hot Stocks news story on USA Technologies »

USA Technologies trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAT

USA Technologies

$7.43

-0.22 (-2.88%)

14:28
09/20/19
09/20
14:28
09/20/19
14:28
Hot Stocks
USA Technologies says unlikely to meet Nasdaq deadline for filing compliance »

USA Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAT

USA Technologies

$7.43

-0.22 (-2.88%)

14:26
09/20/19
09/20
14:26
09/20/19
14:26
Hot Stocks
Breaking Hot Stocks news story on USA Technologies »

USA Technologies trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FISV

Fiserv

$104.82

-0.03 (-0.03%)

14:25
09/20/19
09/20
14:25
09/20/19
14:25
Options
Fiserv call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 27

    Oct

TD

Toronto-Dominion

$57.97

0.4 (0.69%)

, DB

Deutsche Bank

$8.02

-0.055 (-0.68%)

14:24
09/20/19
09/20
14:24
09/20/19
14:24
Hot Stocks
TD accepted Epstein accounts after Deutsche cut ties, Bloomberg says »

Canadian lender…

TD

Toronto-Dominion

$57.97

0.4 (0.69%)

DB

Deutsche Bank

$8.02

-0.055 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

IVV

iShares Core S&P 500

$301.93

-0.845 (-0.28%)

, SPY

SPDR S&P 500 ETF Trust

$298.77

-0.906381 (-0.30%)

14:22
09/20/19
09/20
14:22
09/20/19
14:22
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

ETF fund flows to the top…

IVV

iShares Core S&P 500

$301.93

-0.845 (-0.28%)

SPY

SPDR S&P 500 ETF Trust

$298.77

-0.906381 (-0.30%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$87.41

0.05 (0.06%)

IEF

iShares 7-10 Year Treasury Bond ETF

$111.69

0.335 (0.30%)

ITE

SPDR Bloomberg Barclays Intermediate Term Treasury ETF

$62.19

0.065 (0.10%)

SPTL

SPDR Portfolio Long Term Treasury ETF

$40.45

0.12 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
09/20/19
09/20
14:17
09/20/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
09/20/19
09/20
14:16
09/20/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDD

Pinduoduo

$33.65

-0.98 (-2.83%)

14:15
09/20/19
09/20
14:15
09/20/19
14:15
Options
Pinduoduo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$4.00

0.3347 (9.13%)

14:11
09/20/19
09/20
14:11
09/20/19
14:11
Periodicals
Fitbit deciding whether to explore sale, Reuters says »

Fitbit (FIT) has held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$3.69

0.025 (0.68%)

14:07
09/20/19
09/20
14:07
09/20/19
14:07
Hot Stocks
Fitbit rises after report of hiring bank to consider sale »

Shares of Fitbit are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$3.73

0.06 (1.64%)

14:03
09/20/19
09/20
14:03
09/20/19
14:03
Periodicals
Breaking Periodicals news story on Fitbit »

Fitbit in talks with bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$122.80

-5.865 (-4.56%)

13:55
09/20/19
09/20
13:55
09/20/19
13:55
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DELL

Dell Technologies

$52.26

-0.8 (-1.51%)

13:53
09/20/19
09/20
13:53
09/20/19
13:53
Conference/Events
Dell Technologies to hold a business news update meeting »

CFO Sweet, along with SVP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Nov

FTR

Frontier Communications

$1.00

-0.0006 (-0.06%)

13:43
09/20/19
09/20
13:43
09/20/19
13:43
Periodicals
Frontier Communications prepares for debt restructuring talks, WSJ reports »

Frontier Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:40
09/20/19
09/20
13:40
09/20/19
13:40
General news
U.S. equity markets »

U.S. equity markets were…

BTU

Peabody Energy

$15.47

-1.56 (-9.16%)

, ARCH

Arch Coal

$71.00

-5.37 (-7.03%)

13:39
09/20/19
09/20
13:39
09/20/19
13:39
Hot Stocks
Peabody Energy confirms commitment to pending PRB/Colorado joint venture »

Peabody (BTU) confirmed…

BTU

Peabody Energy

$15.47

-1.56 (-9.16%)

ARCH

Arch Coal

$71.00

-5.37 (-7.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.